Hydroxycamptothecin-induced apoptosis in hepatoma SMMC-7721 cells and the role of mitochondrial pathway

Mitochondrion

Volumn 6, Issue 4, 2006, Pages 211-217

  Fu, Yu Rong ^a   Yi, Zheng Jun ^a   Yan, Yu Rong ^a   Qiu, Zong Yin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

AIF; Apoptosis; Cytochrome c; Hydroxycamptothecin (HCPT); Mitochondria; SMMC 7721

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; APOPTOSIS INDUCING FACTOR; CAMPTOTHECIN DERIVATIVE; CYTOCHROME C; DNA TOPOISOMERASE INHIBITOR; HYDROXYCAMPTOTHECIN; MESSENGER RNA; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL GROWTH; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG EXPOSURE; DRUG MECHANISM; DRUG STRUCTURE; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50; INTRACELLULAR TRANSPORT; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; TIME; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; CAMPTOTHECIN; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; CYTOPLASM; DNA FRAGMENTATION; ENZYME INHIBITORS; HEPATOCYTES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; TETRAZOLIUM SALTS; THIAZOLES;

EID: 33748622045     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2006.07.005     Document Type: Article

References (24)

1. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., and Akey C.W. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9 2 (2002) 423-432
2. Ajani J.A. Current status of therapy for advanced gastric carcinoma. Oncology 12 8 Suppl. 6 (1998) 99-102
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
4. Borel E., Mayencon M., Kaiser K., Picot S., and Peyron F. Fluorogenic detection of viable Toxoplasma gondii. Parasite 5 4 (1998) 371-373
5. Daugas E., Susin S.A., Zamzami N., Ferri K.F., Irinopoulou T., Larochette N., Prevost M.C., Leber B., Andrews D., Penninger J., and Kromer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14 (2000) 729-739
6. Du C.Y., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
7. Dumont C., Durrbach A., Bidere N., Rouleau M., Kroemer G., Bernard G., Hirsch F., Charpentier B., Susin S.A., and Senik A. Caspase-independent commitment phase to apoptosis in activated blood Tlymphocytes: reversibility at low apoptotic insult. Blood 96 3 (2000) 1030-1038
8. Ferri K.F., and Kroemer G. Control of apoptotic DNA degradation [news]. Nat. Cell Biol. 2 (2000) E63-E64
9. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 5684 (2004) 626-629
10. Jin Z., and E1-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 4 2 (2005) 39-63
11. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y., Sasaki T., Elia A.J., Cheng H.Y., Ravagnan L., Ferri K.F., Zamzami N., Wakeham A., Hakem R., Yoshida H., Kong Y.Y., Mak T.W., Zuniga-Pflucker J.C., Kroemer G., and Penningerm J.M. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410 (2001) 549-554
12. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat. Med. 6 5 (2000) 513-519
13. Lee D.J., Hahm K.S., Park Y., Kim H.Y., Lee W., Lim S.C., Seo Y.K., and Choi C.H. Functional and structural characteristics of anticancer peptide Pep27 analogues. Cancer Cell Int. 5 (2005) 1-34
14. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
15. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112 4 (2003) 481-490
16. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol. Lett. 149 1-3 (2004) 19-23
17. Pommier Y., Pourquier P., Fan Y., and Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400 1-3 (1998) 83-105
18. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., and Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17 6 (1998) 1675-1687
19. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., and Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
20. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8 3 (2001) 613-621
21. Vieira O., Escargueil-Blanc I., Jürgens G., Borner C., Almeida L., Salvayre R., and Negre-Salvayre A. Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J. 14 3 (2000) 532-542
22. Widlak P., Li L.Y., Wang X., and Garrard W.T. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: cooperation with exonuclease and DNase I. J. Biol. Chem. 276 51 (2001) 48404-48409
23. Yuste V.J., Sanchez-Lopez I., Sole C., Moubarak R.S., Bayascas J.R., Dolcet X., Encinas M., Susin S.A., and Comella J.X. The contribution of apoptosis inducing factor, caspase activated DNase and inhibitor of caspase activated Dnase to the nuclear phenotype and degradation during apoptosis. J. Biol. Chem. 280 42 (2005) 5670-5683
24. Zhang Z.W., Patchett S.E., and Farthing M.J. Topoisomerase I inhibitor (camptothecin)-induced apoptosis in human gastric cancer cells and the role of wild-type p53 in the enhancement of its cytotoxicity. Anticancer Drugs 11 9 (2000) 57-64